These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Some scientists are displeased that, as mandated in Congress's 1992 reauthorization of the SBIR program, the portion of NIH's R&D budget designated for SBIR is set to grow from 2 percent in 1996 to ...

The study section, scheduled for Tuesday and Wednesday, is reviewing a set of proposals on skeletal biology and regeneration.

As an organization founded with an SBIR NIH/NCI grant to develop a patient-centric, AI-driven Deep Learning Clinical Trial ...

Small Business Innovation Research ("SBIR") and Small Business Technology Transfer ("STTR") are two types of federal award mechanisms that allow start-up and small companies to compete for federal ...

Trump reversed an order requiring federal agencies to freeze grants and loans, but programs at odds with his executive orders ...

It's not yet clear whether the NIH matter will reach USAID-levels of intensity among Democrats and the media. But it's off to a strong start.

In a year marked by significant volatility, Marker Therapeutics Inc. (NASDAQ:MRKR) stock has registered a new 52-week low, dipping to $2.4. The biopharmaceutical company, which specializes in the ...

The Rule is effective on January 17, 2025. To maximize protection of SBIR/STTR data rights, government contractors should: (1) carefully review their contracts and subcontracts to identify the ...